5-lipoxygenase-activating protein (FLAP) inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8841295
SERIAL NO

12089706

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AUTOIMMUNE PHARMA LLC589 BROADWAY 4TH FLOOR NEW YORK NY 10012

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haddach, Mustapha San Diego, US 62 476
Hutchinson, John H La Jolla, US 67 1071
Li, Yiwei Lower Gwynedd, US 51 674
Stock, Nicholas Simon San Diego, US 47 540

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 23, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00